The COVID-19 Omicron variant illustrates how essential it is that all countries do their part in genomic surveillance by sequencing samples and sharing data. Read More
Related Articles
Pfizer and BioNTech’s overlooked third partner will distribute the vaccine in China—and it’s facing some resistance
On Nov. 30, Hong Kong’s government announced a rare piece of news that was welcome in all sectors of a politically-divided city battling its fourth wave of COVID-19 infections: The vaccines are on their way. Hong Kong had purchased 7.5 million doses of a vaccine co-developed by U.S. pharmaceutical giant Pfizer and German vaccine maker […]
The Girls Linking the Biden-Harris Government
President-elect Joe Biden is building his Cabinet, also is expected to announce his own whole pair of nominations on Tuesday. Meanwhile, the former vice president has {} a number of his options to the general public, and various news outlets have reported {} probable selections. Biden faces strain to both innovative and moderates–to receive his […]
Bayer strikes deal to aid CureVac in its COVID-19 vaccine rollout
The German biopharma firm CureVac has announced a tie-up with the country’s biggest pharmaceutical beast, Bayer, for the development and supply of CureVac’s candidate COVID-19 vaccine. The companies did not disclose the financial terms of the deal. Bayer’s stock jumped more than 2% on the news Thursday morning. The collaboration and services agreement should aid […]